What's new

PSUSA/00001842/202410

PSUSA/00001842/202410

Jun 6, 2025 - 11:00
 0
PSUSA/00001842/202410
PSUSA/00001842/202410
Read More

Tags:

Previous Article

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 2...

Next Article

Human medicines European public assessment report (EPAR): Epruvy (previously Ran...

Related Posts

ICH E21 Guideline on inclusion of pregnant and breastfe...

Jun 4, 2025  0

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Human medicines European public assessment report (EPAR): Flucelvax, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 15/11/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0